Patents by Inventor Klaus Muehlegger

Klaus Muehlegger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6875859
    Abstract: The invention concerns compounds of the general formula (I) in which the residues R1 to R7 have the meanings given in the application as well as methods for their preparation.
    Type: Grant
    Filed: March 11, 2002
    Date of Patent: April 5, 2005
    Assignee: Roche Diagnostics GmbH
    Inventors: Klaus Mühlegger, Herbert Von Der Eltz
  • Publication number: 20040214221
    Abstract: Subjects of the inventions are methods for enzymatic DNA labeling. Nucleotides modified to carry functional or detectable groups are incorporated into newly synthesized DNA by DNA polymerases. DNA is synthesized from modified nuleoside triphosphates by DNA polymerases such that the newly synthesized DNA consists exclusively of modified nucleotides or contains modified nucleotides in high density.
    Type: Application
    Filed: May 19, 2004
    Publication date: October 28, 2004
    Inventors: Klaus Muehlegger, Bernhard Angerer, Frank Seela, Waltraud Ankenbauer, Martin Augustin, Karin Gumbiowski, Matthias Zulauf
  • Patent number: 6573374
    Abstract: Nucleoside-5′-triphosphates and phosphoramidites which carry a residue absorbing in the long wavelength region, preferably a carbocyanine group of the general formula (I), on the base portion or on the phosphorus atom in which R1 and R2 each denote hydrogen or together form a phenyl residue; R3 denotes hydrogen if linkage with the nucleotide is via the R4 position or it denotes a —NHCS— group if linkage with the nucleotide is via the R3 position; both R4 and R5, or R5, alone denote an alkylsulfonyl group with n being a number from 3 to 5 or R4 represents a —NHCS— group with n being a number from 3 to 8, as well as the use of the compounds to label, detect and sequence nucleic acids.
    Type: Grant
    Filed: March 28, 1995
    Date of Patent: June 3, 2003
    Assignee: Boehringer Mannheim GmbH
    Inventors: Klaus Muehlegger, Hans-Joachim Hoeltke, Christian Birkner, Herbert Von Der Eltz
  • Patent number: 6498241
    Abstract: 2′-Deoxyisoguanosine, isosteric analogues and isoguanosine derivatives of formulae I-V, processes for their production via compounds of the general formulae a or b and reaction with aroyl isocyanates or from compounds of the general formulae VI-IX by photochemical irradiation. A further production process is the conversion of deoxyguanosines or guanosines by means of persilylation, reaction with ammonia and deamination in the 2 position. The compounds are suitable as pharmaceutical agents with antiviral efficacy.
    Type: Grant
    Filed: November 13, 2000
    Date of Patent: December 24, 2002
    Assignee: Roche Diagnostics GmbH
    Inventors: Frank Seela, Zigmunt Kasimierczuk, Klaus Mühlegger, Herbert Von Der Eltz
  • Patent number: 6403786
    Abstract: The invention concerns compounds of the general formula (I) in which i:he residues R1 to R7 have the meanings given in the application as well as methods for their preparation. The compounds are in particular suitable as substrates for RNA or DNA polymerases and can thus be incorporated into RNA or DNA oligonucleotides and are especially suitable for labelling and detecting nucleic acids or for DNA sequencing.
    Type: Grant
    Filed: July 2, 1999
    Date of Patent: June 11, 2002
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Klaus Mühlegger, Herbert Von der Eltz
  • Patent number: 6320035
    Abstract: The invention concerns pyrrolo-[3,2-d]pyrimidine, pyrazolo-[4,3-d]pyrimidine and pyrimidine-furanosides i.e. so-called C-nucleosides of the general formulae I-V or appropriate derivatives as well as processes for their production.
    Type: Grant
    Filed: October 25, 2000
    Date of Patent: November 20, 2001
    Assignee: Roche Diagnostics GmbH
    Inventors: Klaus Mühlegger, Herbert Von Der Eltz, Frank Seela, Helmet Rosemeyer
  • Patent number: 6211158
    Abstract: The present invention provides desazapurine-nucleoside derivatives of the general formula: wherein X is a nitrogen atom or a methine radical, W is a nitrogen atom or a C—R4 radical, R1, R2, R3 and R4, which can be the same or different, are hydrogen or halogen atoms, hydroxyl or mercapto groups, lower alkyl, lower alkylthio, lower alkoxy, aralkyl, aralkoxy or aryloxy radicals or amino groups optionally substituted once or twice, R5 is a hydrogen atom or a hydroxyl group, R6 and R7 are each hydrogen atoms or one of them is a halogen atom or a cyano or azido group or an amino group optionally substituted once or twice, whereby one of R6 and R7 can also be a hydroxyl group when X is a methine radical and, in addition, R5 and R7 can together also represent a further valency bond between C-2′ and C-3′ and Y is a hydrogen atom or a mono-, di- or tri-phosphate group.
    Type: Grant
    Filed: June 26, 1992
    Date of Patent: April 3, 2001
    Assignee: Roche Diagnostics GmbH
    Inventors: Frank Seela, Heinz-Peter Muth, Klaus Kaiser, Werner Bourgeois, Klaus Mühlegger, Herbert Von der Eltz, Hans-Georg Batz
  • Patent number: 5756704
    Abstract: Process for the production of oligonucleotides of formula II, in which the exocyclic amino groups of the bases adenine, guanine, cytosine, 7-deazaadenine and 7-deazaguanine carry N-phenylacetyl groups, are used for oligonucleotide synthesis, wherein in a first step a starting nucleotide is bound to a solid carrier, subsequently the desired oligonucleotide is synthesized by stepwise coupling with appropriately activated further monomeric nucleotide building blocks of the general formula I with the above-mentioned meanings, if desired, trivalent phosphorus is oxidized to pentavalent phosphorus during and after the synthesis, the oligonucleotide is cleaved from the carrier and the 5' protecting groups are cleaved off. The phenylacetyl functional groups that protect exocyclic NH.sub.2 groups of the bases can be cleaved off in a mild way with penicillin amidohydrolase (EC 3.5.1.11).
    Type: Grant
    Filed: April 18, 1997
    Date of Patent: May 26, 1998
    Assignee: Boehringer Mannheim GmbH
    Inventors: Herbert Waldman, Armin Reidel, Axel Heuser, Klaus Muehlegger, Herbert Von Der Eltz, Christian Birkner
  • Patent number: 5677441
    Abstract: Process for the production of oligonucleotides of formula II, in which the exocyclic amino groups of the bases adenine, guanine, cytosine, 7-deazaadenine and 7-deazaguanine carry N-phenylacetyl groups, are used for oligonucleotide synthesis, wherein in a first step a starting nucleotide is bound to a solid carrier, subsequently the desired oligonucleotide is synthesized by stepwise coupling with appropriately activated further monomeric nucleotide building blocks of the general formula I with the above-mentioned meanings, if desired, trivalent phosphorus is oxidized to pentavalent phosphorus during and after the synthesis, the oligonucleotide is cleaved from the carrier and the 5' protecting groups are cleaved off. The phenylacetyl functional groups that protect exocyclic NH.sub.2 groups of the bases can be cleaved off in a mild way with penicillin amidohydrolase (EC 3.5.1.11).
    Type: Grant
    Filed: October 20, 1994
    Date of Patent: October 14, 1997
    Assignee: Boehringer Mannheim GmbH
    Inventors: Herbert Waldman, Armin Reidel, Axel Heuser, Klaus Muehlegger, Herbert Von Der Eltz, Christian Birkner